SEC Form 4 · accession 0000874015-17-000061
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard S Geary
Officer — SVP, Development
Period of report
Oct 13, 2017
Accepted (ET)
Oct 17, 2017 · 5:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 13, 2017 | S | 807 | $60.00 | D | 12,351 | D | |
| Common StockF2 | Oct 13, 2017 | M | 426 | $10.29 | A | 12,777 | D | |
| Common StockF2 | Oct 13, 2017 | S | 426 | $60.00 | D | 12,351 | D | |
| Common StockF2 | Oct 13, 2017 | M | 7,035 | $7.25 | A | 19,386 | D | |
| Common StockF2 | Oct 13, 2017 | S | 7,035 | $60.00 | D | 12,351 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $10.29 | Oct 13, 2017 | M | 426 | D | Jan 3, 2015 | Jan 2, 2018 | Common Stock | 426 | 0 | D |
| Employee Stock Option (right to buy) | $7.25 | Oct 13, 2017 | M | 7,035 | D | Jan 3, 2016 | Jan 2, 2019 | Common Stock | 7,035 | 0 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/2/2016.
- F2Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 12/2/2016.